Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Changhai Hospital
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
pNETs lesions pathologically classified as WHO grade 1/ 2/ 3;
G2/3-NET with at least one high-risk postoperative recurrence factor, including but not limited to lymph node metastasis, neurovascular invasion, pancreatic duct dilation, tumor \>4cm, positive resection margin, etc.; or G1-NET with lymph node or remote transfer;
Complete surgical resection (R0 or R1 was achieved) ;
Adjuvant treatment was performed within 6-12 weeks after surgery;
Have received whole-body 68Ga PET-CT examination within the past six months;
You may not be if
Urinalysis shows urine protein ≥ 2+ and 24-hour protein quantity test shows urinary protein ≥1 g;
Under anti-hypertension treatment, still uncontrolled hypertension, defined as: systolic blood pressure ≥ 150 mmHg or diastolic blood pressure ≥ 100 mmHg;
Clinically significant cardiovascular disease, including but not limited to, acute myocardial infarction within 6 months prior to enrollment, severe/unstable angina pectoris or coronary artery bypass grafting, congestive heart failure according to the New York Heart Association (NYHA) classification ≥ 2; ventricular arrhythmias which needs drug treatment; LVEF (LVEF) \<50%;
Clareo Health | A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors
